# Re-biopsy for advanced non-small cell lung cancer after EGFR tyrosine kinase inhibitor therapy: CT characteristics of patients with T790M mutation and the use of various re-biopsy procedures

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/re-biopsy-for-advanced-non-small-cell-lung-cancer-after-egfr-tyrosine-kinase/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hyun Jung Koo,Mi Young Kim,Chang‐Min Choi,J.C. Lee,S. Park |
| Citations | 0 |
| DOI | 10.1093/annonc/mdx091.023 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.annalsofoncology.org/article/S0923-7534(19)33597-5/pdf |
| OpenAlex ID | https://openalex.org/W2612940913 |
| Type | article |
| Year | 2017 |

## Paper authors

- [J.C. Lee](https://scholariq.org/researchers/j-c-lee/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.